Clinical Laserthermia Systems
16.25 SEK -0.67%1 investor is following this company
Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.
Revenue
8.27M
EBIT %
-797.22 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
CLS B
Daily low / high price
15.95 / 16.946
SEK
Market cap
127.59M SEK
Turnover
381.55K SEK
Volume
24K
Financial calendar
Interim report
17.05.2024
General meeting
28.06.2024
Interim report
23.08.2024
Interim report
15.11.2024
Annual report
21.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 7.1 % | 6.8 % |
Handelsbanken Liv Försäkringsaktiebolag | 4.7 % | 4.6 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
CLS: Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split
CLS: Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools